DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 021060
NDA 021060 describes PRIALT, which is a drug marketed by Tersera Theraps Llc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the PRIALT profile page.
The generic ingredient in PRIALT is ziconotide acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ziconotide acetate profile page.
The generic ingredient in PRIALT is ziconotide acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ziconotide acetate profile page.
Summary for 021060
| Tradename: | PRIALT |
| Applicant: | Tersera Theraps Llc |
| Ingredient: | ziconotide acetate |
| Patents: | 3 |
Generic Entry Opportunity Date for 021060
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 021060
| Mechanism of Action | N-Calcium Channel Receptor Antagonists |
Suppliers and Packaging for NDA: 021060
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060 | NDA | Jazz Pharmaceuticals, Inc. | 18860-720 | 18860-720-10 | 1 VIAL, GLASS in 1 CARTON (18860-720-10) > 1 mL in 1 VIAL, GLASS |
| PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060 | NDA | Jazz Pharmaceuticals, Inc. | 18860-722 | 18860-722-10 | 1 VIAL, GLASS in 1 CARTON (18860-722-10) > 5 mL in 1 VIAL, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRATHECAL | Strength | 500MCG/20ML (25MCG/ML) | ||||
| Approval Date: | Dec 28, 2004 | TE: | RLD: | Yes | |||||
| Patent: | ➤ Sign Up | Patent Expiration: | Oct 1, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | ANALGESIA | ||||||||
| Patent: | ➤ Sign Up | Patent Expiration: | Oct 1, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | TREATMENT OF PAIN | ||||||||
| Patent: | ➤ Sign Up | Patent Expiration: | Oct 1, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | ANALGESIA | ||||||||
Expired US Patents for NDA 021060
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-001 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-004 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-004 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-001 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-002 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-003 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Tersera Theraps Llc | PRIALT | ziconotide acetate | INJECTABLE;INTRATHECAL | 021060-003 | Dec 28, 2004 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription
